Biocardia Stock Price on September 23, 2024
| BCDA Stock | USD 2.26 0.13 6.10% |
If you're considering investing in Biocardia Stock, it is important to understand the factors that can impact its price. As of today, the current price of Biocardia stands at 2.26, as last reported on the 23rd of November, with the highest price reaching 2.32 and the lowest price hitting 2.14 during the day. Biocardia appears to be extremely dangerous, given 3 months investment horizon. Biocardia secures Sharpe Ratio (or Efficiency) of 0.0208, which signifies that the company had a 0.0208% return per unit of risk over the last 3 months. We have found thirty technical indicators for Biocardia, which you can use to evaluate the volatility of the firm. Please makes use of Biocardia's Mean Deviation of 6.21, risk adjusted performance of 0.0254, and Downside Deviation of 7.19 to double-check if our risk estimates are consistent with your expectations.
Biocardia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Biocardia |
Sharpe Ratio = 0.0208
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BCDA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.3 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.26 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Biocardia is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biocardia by adding it to a well-diversified portfolio.
Related Headline
Rezolute Headline on 23rd of September 2024
Acquisition by Daron Evans of 100000 shares of Rezolute at 4... by MacroaxisInsider
Filed transaction by Rezolute Officer: Cfo. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Biocardia Valuation on September 23, 2024
It is possible to determine the worth of Biocardia on a given historical date. On September 23, 2024 Biocardia was worth 2.6 at the beginning of the trading date compared to the closed value of 2.47. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Biocardia stock. Still, in general, we apply an absolute valuation method to find Biocardia's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biocardia where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Biocardia's related companies.
| Open | High | Low | Close | Volume | |
| 2.95 | 2.95 | 2.50 | 2.54 | 545,210 | |
09/23/2024 | 2.60 | 2.70 | 2.45 | 2.47 | 134,267 |
| 2.50 | 2.53 | 2.34 | 2.41 | 128,764 |
| Backtest Biocardia | | | Biocardia History | | | Biocardia Valuation | Previous | Next |
Biocardia Trading Date Momentum on September 23, 2024
| On September 24 2024 Biocardia was traded for 2.41 at the closing time. The top price for the day was 2.53 and the lowest listed price was 2.34 . The trading volume for the day was 128.8 K. The trading history from September 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 2.43% . The overall trading delta against the current closing price is 10.12% . |
Biocardia Fundamentals Correlations and Trends
By evaluating Biocardia's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Biocardia's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Biocardia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Biocardia Stock history
Biocardia investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Biocardia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Biocardia will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Biocardia stock prices may prove useful in developing a viable investing in Biocardia
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart and Morph deflectable guides and sheaths. Biocardia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.
Biocardia Stock Technical Analysis
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Biocardia Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Biocardia cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Biocardia November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Biocardia stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biocardia shares will generate the highest return on investment. By undertsting and applying Biocardia stock market strength indicators, traders can identify Biocardia entry and exit signals to maximize returns
Biocardia Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Biocardia's price direction in advance. Along with the technical and fundamental analysis of Biocardia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Biocardia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0254 | |||
| Jensen Alpha | (0.1) | |||
| Total Risk Alpha | (1.69) | |||
| Sortino Ratio | 0.0175 | |||
| Treynor Ratio | 0.0863 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Biocardia Stock analysis
When running Biocardia's price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |